Page last updated: 2024-10-22

albuterol and Peripheral Vascular Diseases

albuterol has been researched along with Peripheral Vascular Diseases in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Peripheral Vascular Diseases: Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kals, J1
Kampus, P1
Kals, M1
Pulges, A1
Teesalu, R1
Zilmer, M1

Other Studies

1 other study available for albuterol and Peripheral Vascular Diseases

ArticleYear
Effects of stimulation of nitric oxide synthesis on large artery stiffness in patients with peripheral arterial disease.
    Atherosclerosis, 2006, Volume: 185, Issue:2

    Topics: Adrenergic beta-Agonists; Albuterol; Aorta; Arterial Occlusive Diseases; Arteries; Blood Flow Veloci

2006